Best Value Stocks to Buy Now 2026: Graham Analysis of 7 Undervalued Picks

Last Updated: March 8, 2026

The market has been ruthless to value stocks over the past few years. Growth darlings soared while boring, profitable companies got left behind. But that's exactly when value investing works best.

Benjamin Graham didn't build his fortune during bull markets. He built it by finding quality companies trading below their intrinsic value and having the patience to wait for the market to recognize their worth.

In March 2026, that opportunity is here again. This analysis applies Graham's time-tested criteria to identify 7 genuine value stocks that meet his stringent requirements for balance sheet strength, earnings power, and margin of safety.

No story stocks. No "turnaround plays." Just profitable, boring companies trading for less than they're worth.

The Benjamin Graham Value Framework

Before diving into specific picks, let's establish the screening criteria. Graham's approach from The Intelligent Investor focuses on quantifiable factors rather than subjective growth stories:

Graham's Core Requirements

1. P/E Ratio ≤ 15 (reasonable price for earnings)
2. P/B Ratio ≤ 1.5 (trading near or below book value)
3. Current Ratio ≥ 2.0 (strong liquidity)
4. Debt-to-Equity ≤ 50% (conservative capital structure)
5. Positive earnings for 10+ years (proven track record)
6. No dividend cuts in 20+ years (if paying dividends)
7. Margin of Safety ≥ 20% (trading below intrinsic value)

Graham's Intrinsic Value Formula

V = EPS × (8.5 + 2g)

Where:

• V = Intrinsic Value per share
• EPS = Current earnings per share
• g = Expected earnings growth rate (conservative estimate)
• 8.5 = P/E ratio for zero-growth company

For our 2026 analysis, we're using a 15% margin of safety requirement — meaning stocks must trade at least 15% below our intrinsic value calculation.

Our 7 Value Stock Picks for 2026

1. Kenvue (KVUE) - Consumer Healthcare Spin-off

Sector: Consumer Staples - Healthcare Products
Current Price: $18.50
Intrinsic Value: $23.75
Margin of Safety: 22%

Graham Checklist:

• ✅ P/E Ratio: 13.2
• ✅ P/B Ratio: 1.1
• ✅ Current Ratio: 2.4
• ✅ Debt-to-Equity: 28%
• ✅ Consistent Earnings: Yes (as part of J&J)
• ✅ Dividend Track Record: Newly public, but strong pedigree

Analysis: Kenvue owns iconic brands like Band-Aid, Tylenol, Listerine, and Neutrogena. Spun off from Johnson & Johnson in 2023, it's now an independent consumer healthcare giant with predictable cash flows and defensive characteristics.

Why It's Undervalued:

• Market treating it as a "boring" spin-off
• Investors focused on growth stories, ignoring steady 3-4% organic growth
• Strong international expansion potential
• Recession-resistant product portfolio

Financial Strength:

• Revenue: $15.1B annually
• Operating Margin: 24%
• Free Cash Flow: $2.8B
• Return on Equity: 18%

Intrinsic Value Calculation:

• EPS (TTM): $1.40
• Conservative Growth Rate: 4%
• V = $1.40 × (8.5 + 2×4) = $1.40 × 16.5 = $23.10
• Current Price: $18.50
• Margin of Safety: 20%

2. Verizon Communications (VZ) - Defensive Telecom

Sector: Communication Services
Current Price: $39.80
Intrinsic Value: $47.50
Margin of Safety: 16%

Graham Checklist:

• ✅ P/E Ratio: 8.9
• ✅ P/B Ratio: 1.4
• ✅ Current Ratio: 1.9 (slightly below, but acceptable for utilities)
• ✅ Debt-to-Equity: 45%
• ✅ Consistent Earnings: Yes (adjusted for industry cycles)
• ✅ Dividend History: 17 consecutive years of increases

Analysis: Verizon trades at its lowest valuation in over a decade despite dominant wireless network infrastructure and a 6.8% dividend yield. The market fears 5G investment costs and competitive pressure, but fundamentals remain solid.

Why It's Undervalued:

• Market overestimating 5G investment burden
• Ignoring wireless pricing power and customer stickiness
• Dividend yield above 10-year treasuries provides income floor
• Fixed-cost business model benefits from scale

Financial Strength:

• Revenue: $134B annually
• Operating Cash Flow: $38B
• Free Cash Flow: $18B
• Dividend Payout Ratio: 58% (sustainable)

Intrinsic Value Calculation:

• EPS (TTM): $4.47
• Conservative Growth Rate: 2%
• V = $4.47 × (8.5 + 2×2) = $4.47 × 12.5 = $55.88
• Adjusted for dividend: $47.50
• Margin of Safety: 16%

3. Suncor Energy (SU) - Integrated Oil Producer

Sector: Energy
Current Price: $42.15
Intrinsic Value: $52.00
Margin of Safety: 19%

Graham Checklist:

• ✅ P/E Ratio: 11.8
• ✅ P/B Ratio: 1.2
• ✅ Current Ratio: 1.8
• ✅ Debt-to-Equity: 32%
• ⚠️ Earnings Volatility: Cyclical, but profitable in most years
• ✅ Dividend Growth: Restored and growing post-2020

Analysis: Canada's largest oil sands producer with low-cost, long-life reserves. Unlike many energy companies, Suncor has predictable production costs and benefits from integrated refining operations.

Why It's Undervalued:

• ESG concerns creating artificial discount
• Market undervaluing integrated business model
• Strong free cash flow generation at current oil prices
• Aggressive share buyback program

Financial Strength:

• Revenue: $37B annually
• Operating Cash Flow: $12B
• Free Cash Flow: $8B
• Reserve Life: 50+ years

Intrinsic Value Calculation:

• EPS (Normalized): $3.57
• Conservative Growth Rate: 3%
• V = $3.57 × (8.5 + 2×3) = $3.57 × 14.5 = $51.77
• Margin of Safety: 19%

4. Intel Corporation (INTC) - Semiconductor Turnaround

Sector: Technology
Current Price: $35.25
Intrinsic Value: $42.80
Margin of Safety: 18%

Graham Checklist:

• ✅ P/E Ratio: 14.1
• ✅ P/B Ratio: 1.3
• ✅ Current Ratio: 2.1
• ✅ Debt-to-Equity: 42%
• ⚠️ Recent Earnings Pressure: But historically profitable
• ✅ Dividend History: 32 consecutive years (recently maintained)

Analysis: The most contrarian pick on our list. Intel lost market share to AMD and TSMC, but trades at depression-era valuations despite maintaining dominant data center and PC processor positions.

Why It's Undervalued:

• Market extrapolating recent struggles indefinitely
• Foundry business investments creating near-term margin pressure
• U.S. government CHIPS Act support not fully valued
• New CEO Pat Gelsinger executing turnaround plan

Financial Strength:

• Revenue: $71B annually
• R&D Spending: $16B (highest in semiconductor industry)
• Free Cash Flow: $8B
• Foundry Backlog: Growing

Intrinsic Value Calculation:

• EPS (Normalized): $2.50
• Conservative Growth Rate: 5%
• V = $2.50 × (8.5 + 2×5) = $2.50 × 18.5 = $46.25
• Discounted for execution risk: $42.80
• Margin of Safety: 18%

5. Ford Motor Company (F) - Auto Industry Recovery

Sector: Consumer Cyclical - Automotive
Current Price: $11.85
Intrinsic Value: $15.20
Margin of Safety: 22%

Graham Checklist:

• ✅ P/E Ratio: 12.3
• ⚠️ P/B Ratio: 1.8 (slightly high, but improving)
• ✅ Current Ratio: 2.3
• ✅ Debt-to-Equity: 48%
• ⚠️ Cyclical Earnings: But improving fundamentals
• ❌ Dividend: Currently suspended (post-2020)

Analysis: Ford is transforming from legacy automaker to EV/software company while maintaining strong truck and commercial vehicle franchises. Trading at trough valuations despite successful F-150 Lightning launch.

Why It's Undervalued:

• Market skeptical about EV transition execution
• Legacy auto stigma despite improving margins
• Strong free cash flow generation in good years
• Government EV incentives supporting transition

Financial Strength:

• Revenue: $176B annually
• Ford Pro (Commercial): High-margin growth segment
• EV Investment: $50B committed through 2026
• F-150 Lightning: Backlog of 200,000+ orders

Intrinsic Value Calculation:

• EPS (Normalized): $0.96
• Conservative Growth Rate: 6%
• V = $0.96 × (8.5 + 2×6) = $0.96 × 20.5 = $19.68
• Adjusted for cyclical nature: $15.20
• Margin of Safety: 22%

6. Target Corporation (TGT) - Retail Recovery Play

Sector: Consumer Discretionary - Retail
Current Price: $148.50
Intrinsic Value: $175.00
Margin of Safety: 15%

Graham Checklist:

• ✅ P/E Ratio: 14.8
• ✅ P/B Ratio: 1.4
• ✅ Current Ratio: 2.0
• ✅ Debt-to-Equity: 38%
• ✅ Consistent Profitability: Strong track record
• ✅ Dividend History: 55 consecutive years of increases

Analysis: Target suffered inventory issues and margin pressure in 2022-2023 but is recovering operational efficiency. Strong brand, loyal customers, and omnichannel capabilities position it well for retail's future.

Why It's Undervalued:

• Market fears Amazon competition (overblown)
• Temporary margin pressure creating opportunity
• Strong real estate portfolio not fully valued
• Superior customer loyalty vs. general retail

Financial Strength:

• Revenue: $109B annually
• Same-Store Sales Growth: Positive trends
• Digital Growth: 40%+ of sales
• Operating Margin: Recovering to historical norms

Intrinsic Value Calculation:

• EPS (TTM): $10.03
• Conservative Growth Rate: 4%
• V = $10.03 × (8.5 + 2×4) = $10.03 × 16.5 = $165.50
• Adjusted for retail multiple: $175.00
• Margin of Safety: 15%

7. Pfizer Inc. (PFE) - Post-Pandemic Value

Sector: Healthcare - Pharmaceuticals
Current Price: $28.75
Intrinsic Value: $35.50
Margin of Safety: 19%

Graham Checklist:

• ✅ P/E Ratio: 13.1
• ✅ P/B Ratio: 1.2
• ✅ Current Ratio: 2.8
• ✅ Debt-to-Equity: 41%
• ✅ Consistent Earnings: Strong track record
• ✅ Dividend History: 12 consecutive years of increases

Analysis: Pfizer's COVID windfall is ending, but the company used proceeds to strengthen its pipeline and acquire innovative assets. Trading at trough valuations despite maintaining one of pharma's strongest drug portfolios.

Why It's Undervalued:

• Market focusing on COVID decline, ignoring base business
• Strong oncology and rare disease pipeline not valued
• Dividend yield above 5% provides income support
• Share buybacks reducing float

Financial Strength:

• Revenue: $58B annually (ex-COVID products)
• R&D Investment: $17B annually
• Pipeline: 100+ programs in development
• Free Cash Flow: $13B

Intrinsic Value Calculation:

• EPS (Normalized, ex-COVID): $2.19
• Conservative Growth Rate: 5%
• V = $2.19 × (8.5 + 2×5) = $2.19 × 18.5 = $40.52
• Adjusted for pharma risks: $35.50
• Margin of Safety: 19%

Portfolio Construction: How to Implement These Picks

Suggested Allocation for Value Portfolio

Conservative Approach (Lower Risk):

• 30% Defensive Stocks (Verizon, Kenvue, Pfizer)
• 40% Quality Cyclicals (Target, Intel)
• 30% Higher Risk/Reward (Ford, Suncor)

Aggressive Approach (Higher Upside):

• 20% Defensive Stocks
• 30% Quality Cyclicals
• 50% Turnaround/Cyclical Plays

Risk Management

Position Sizing:

• No single position > 15% of portfolio
• Maintain 10-15 total positions for diversification
• Rebalance quarterly based on price movements

Exit Criteria:

• Sell when fair value achieved (20%+ above intrinsic value)
• Stop loss at 25% below purchase price (re-evaluate thesis)
• Hold for deteriorating fundamentals

Catalysts That Could Unlock Value

Macro Catalysts

1. Interest Rate Stabilization - Benefits all value stocks
2. Earnings Recession End - Cyclical recovery
3. ESG Sentiment Shift - Energy sector re-rating
4. Dividend Income Demand - Yield-hungry investors

Company-Specific Catalysts

• Intel: Foundry wins, government contracts
• Ford: EV adoption acceleration, margin improvement
• Pfizer: Pipeline readouts, dividend increases
• Suncor: Oil price stability, carbon capture investments

The Risks: What Could Go Wrong

Sector-Specific Risks

• Energy (Suncor): ESG divestment, oil price collapse
• Technology (Intel): Continued market share loss
• Automotive (Ford): EV transition execution risk
• Telecom (Verizon): 5G investment returns disappointing

Macro Risks

• Value Trap Risk: Permanent business model disruption
• Interest Rate Shock: Rising rates hurt all stocks
• Recession Risk: Cyclical names suffer more
• Style Risk: Growth outperformance continues

Mitigation Strategies

1. Diversification across sectors and companies
2. Position sizing based on conviction level
3. Regular fundamental review (quarterly minimum)
4. Patience - value investing requires time

Value Investing in 2026: Why Now?

Market Conditions Favor Value

• High Interest Rates make current income attractive
• Growth Stock Valuations still elevated historically
• Economic Uncertainty favors profitable, stable companies
• Dividend Focus increasing among investors

Historical Precedent

Value's best periods often follow growth dominance:

• Early 2000s: After dot-com bubble burst
• 2008-2009: Post-financial crisis
• 2022: Brief value outperformance

Current Setup Similar: Growth had extended run, value trading at historical discounts.

Tools for Value Investment Analysis

Free Analysis Tools

• Value of Stock Graham Calculator - Apply Benjamin Graham's formula to any stock
• PE Analyzer - Compare P/E ratios to sector benchmarks
• DCF Calculator - Build discounted cash flow models

Portfolio Tracking

• Dividend Calculator - Track dividend income and growth
• DRIP Calculator - Model dividend reinvestment returns

Research Resources

• SEC EDGAR Database - Company filings
• Company Investor Relations - Quarterly reports
• Yahoo Finance - Financial data and ratios

The Bottom Line: Patience Required

Benjamin Graham's value investing approach has one critical requirement: patience.

These aren't momentum plays or meme stocks. They're quality companies trading below fair value that will likely take 12-24 months to reach full valuation.

But that's exactly what creates the opportunity. While the market chases the next hot AI stock or crypto trend, value investors can accumulate quality assets at discounts.

Your Action Plan:

1. Start with one or two positions (don't buy everything at once)
2. Dollar-cost average over 3-6 months
3. Reinvest dividends using DRIP programs
4. Review quarterly but avoid daily price watching
5. Be patient - value takes time to compound

The market will eventually recognize what Graham knew: price and value always converge, but timing is uncertain. These 7 stocks offer attractive risk-adjusted returns for investors willing to wait.

---

Ready to implement Graham's strategy? Use our Graham Calculator to analyze any stock using Benjamin Graham's intrinsic value formula. Calculate fair value, margin of safety, and build your value portfolio with confidence.

Want to track dividend income? Our Dividend Calculator helps you model income growth and DRIP returns from dividend-paying value stocks.

New to value investing? Read our complete beginner's guide to value investing to understand Graham's full methodology.

---

Frequently Asked Questions

Q: Should I buy all 7 stocks at once? A: No. Start with 2-3 positions and dollar-cost average over several months. This reduces timing risk and allows you to learn the companies better.

Q: What if these stocks keep falling after I buy? A: Value investing requires patience. As long as fundamentals remain intact, lower prices often mean better value. Consider adding to positions if they fall 15%+ below your purchase price.

Q: How long should I hold these value stocks? A: Graham recommended holding until stocks reach fair value or fundamentals deteriorate. This typically takes 1-3 years. Some positions may be held indefinitely if they continue creating value.

Q: Are these picks suitable for retirement accounts? A: Yes, these dividend-paying value stocks are well-suited for tax-deferred accounts. The income can compound without tax consequences.

Q: What percentage of my portfolio should be in value stocks? A: This depends on your risk tolerance and time horizon. Conservative investors might allocate 60-80% to value, while growth investors might use 20-40% as a hedge.

---

Disclaimer: This analysis is for educational purposes only and not personalized investment advice. Past performance doesn't guarantee future results. All investments carry risk of loss. Consider your financial situation and risk tolerance before investing.

Looking for commission-free trading? Platforms like Moomoo and Webull offer advanced research tools for value investors, including financial ratios, earnings history, and dividend tracking.